Max Healthcare Institute Limited Share Price
Equities
MAXHEALTH
INE027H01010
Healthcare Facilities & Services
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,064.20 INR | -1.35% |
|
-4.74% | -5.64% |
| 12-03 | Indian Equities Ease on Wednesday as Rupee Weakness, Foreign Outflows Persist | MT |
| 12-01 | Indian Equities End Flat Again on Monday as Rupee Hits Fresh Low | MT |
| Capitalization | 1,049B 11.64B 10.02B 9.4B 8.74B 16.11B 17.58B 110B 42.43B 495B 43.67B 42.74B 1,815B | P/E ratio 2026 * |
58x | P/E ratio 2027 * | 46.5x |
|---|---|---|---|---|---|
| Enterprise value | 1,069B 11.86B 10.21B 9.59B 8.91B 16.42B 17.92B 112B 43.25B 505B 44.52B 43.57B 1,850B | EV / Sales 2026 * |
10.2x | EV / Sales 2027 * | 8.33x |
| Free-Float |
76.26% | Yield 2026 * |
0.18% | Yield 2027 * | 0.19% |
Last Transcript: Max Healthcare Institute Limited
| 15/09/22 | Max Healthcare Institute : ESOP/ESPS/SBEB Scheme | PU |
| 18/08/22 | Max Healthcare Institute : News Verification | PU |
| 09/08/22 | Max Healthcare Institute : Insider Trading - Others | PU |
| 04/04/22 | Max Healthcare Institute : Postal Ballot | PU |
| 1 day | -1.28% | ||
| 1 week | -4.74% | ||
| Current month | -8.43% | ||
| 1 month | -3.03% | ||
| 3 months | -7.61% | ||
| 6 months | -10.81% | ||
| Current year | -5.64% |
| 1 week | 1,061.5 |  | 1,120 |
| 1 month | 1,061.5 | | 1,187.25 |
| Current year | 940.35 | | 1,314.3 |
| 1 year | 940.35 | | 1,314.3 |
| 3 years | 412 | | 1,314.3 |
| 5 years | 128.05 | | 1,314.3 |
| 10 years | 64.95 | | 1,314.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Abhay Soi
CEO | Chief Executive Officer | 52 | 31/05/2020 |
| Director of Finance/CFO | 61 | 14/01/2012 | |
Dhiraj Aroraa
CMP | Compliance Officer | - | 02/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Abhay Soi
CHM | Chairman | 52 | 20/06/2019 |
Michael Neeb
BRD | Director/Board Member | 63 | 20/06/2019 |
| Director/Board Member | 69 | 20/06/2019 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0.04% | 51 M€ | +4.72% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.35% | -4.74% | -4.62% | +146.16% | 11.86B | |
| -0.32% | -3.55% | +51.73% | +100.87% | 111B | |
| +1.19% | -3.25% | +38.42% | -25.36% | 96.01B | |
| -0.31% | +2.59% | +41.28% | +77.04% | 31.16B | |
| -1.23% | +4.92% | -11.54% | +16.89% | 24.17B | |
| +0.60% | -2.91% | +11.77% | +10.29% | 21.42B | |
| -0.38% | -1.06% | +15.55% | +20.81% | 20.3B | |
| -1.76% | -4.10% | +48.49% | +367.61% | 18.46B | |
| +0.86% | -2.67% | +62.34% | +60.29% | 17.98B | |
| -2.14% | -5.55% | +16.43% | +74.47% | 14.44B | |
| Average | -0.48% | -1.93% | +26.98% | +84.91% | 36.69B | |
| Weighted average by Cap. | -0.05% | -2.27% | +36.00% | +62.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 105B 1.17B 1B 942M 876M 1.61B 1.76B 10.98B 4.25B 49.61B 4.37B 4.28B 182B | 128B 1.41B 1.22B 1.14B 1.06B 1.96B 2.14B 13.32B 5.16B 60.21B 5.31B 5.2B 221B |
| Net income | 18.17B 202M 173M 163M 151M 279M 304M 1.9B 735M 8.58B 756M 740M 31.42B | 22.78B 253M 217M 204M 190M 350M 382M 2.38B 921M 10.75B 948M 928M 39.4B |
| Net Debt | 20.34B 226M 194M 182M 169M 312M 341M 2.12B 822M 9.6B 847M 828M 35.18B | 12.73B 141M 122M 114M 106M 195M 213M 1.33B 515M 6.01B 530M 518M 22.02B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/12/25 | 1,064.20 ₹ | -1.35% | 15,436 |
| 08/12/25 | 1,078.80 ₹ | -1.74% | 72,938 |
| 05/12/25 | 1,097.95 ₹ | +1.41% | 21,512 |
| 04/12/25 | 1,082.65 ₹ | -0.33% | 66,889 |
| 03/12/25 | 1,086.20 ₹ | -2.84% | 138,306 |
Delayed Quote Bombay S.E., December 09, 2025 at 05:26 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MAXHEALTH Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition